Literature DB >> 2205946

Corticosteroids and osteoporosis.

R Smith1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2205946      PMCID: PMC462622          DOI: 10.1136/thx.45.8.573

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  21 in total

1.  Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica.

Authors:  D M Reid; J J Nicoll; M A Smith; B Higgins; P Tothill; G Nuki
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-06

2.  Correction of corticosteroid-induced osteoporosis by percutaneous hormone implants.

Authors:  J W Studd; M Savvas; M Johnson
Journal:  Lancet       Date:  1989-02-11       Impact factor: 79.321

3.  Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis.

Authors:  A J Stellon; A Webb; J E Compston
Journal:  Gut       Date:  1988-03       Impact factor: 23.059

Review 4.  Endocrinology and osteoporosis.

Authors:  P L Selby; R M Francis
Journal:  J Endocrinol       Date:  1988-04       Impact factor: 4.286

Review 5.  Acanthamoeba keratitis.

Authors: 
Journal:  Lancet       Date:  1988-03-26       Impact factor: 79.321

6.  The effect of single oral doses of prednisone on the circadian rhythm of serum osteocalcin in normal subjects.

Authors:  H K Nielsen; P Charles; L Mosekilde
Journal:  J Clin Endocrinol Metab       Date:  1988-11       Impact factor: 5.958

7.  Recovery from steroid-induced osteoporosis.

Authors:  N A Pocock; J A Eisman; C R Dunstan; R A Evans; D H Thomas; N L Huq
Journal:  Ann Intern Med       Date:  1987-09       Impact factor: 25.391

8.  Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy.

Authors:  O S Gluck; W A Murphy; T J Hahn; B Hahn
Journal:  Arthritis Rheum       Date:  1981-07

9.  Association of cytomegalovirus infection with autoimmune type 1 diabetes.

Authors:  C Y Pak; H M Eun; R G McArthur; J W Yoon
Journal:  Lancet       Date:  1988-07-02       Impact factor: 79.321

10.  Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).

Authors:  I R Reid; A R King; C J Alexander; H K Ibbertson
Journal:  Lancet       Date:  1988-01-23       Impact factor: 79.321

View more
  7 in total

1.  Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma.

Authors:  R J Meijer; H A Kerstjens; L R Arends; H F Kauffman; G H Koëter; D S Postma
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

2.  Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years.

Authors:  A E Tattersfield; G I Town; O Johnell; C Picado; M Aubier; P Braillon; R Karlström
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

3.  Context-dependent effects of feather corticosterone on growth rate and fledging success of wild passerine nestlings in heterogeneous habitat.

Authors:  Jaanis Lodjak; Marko Mägi; Uku Rooni; Vallo Tilgar
Journal:  Oecologia       Date:  2015-05-30       Impact factor: 3.225

4.  Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care.

Authors:  M L Levy; C Stevenson; T Maslen
Journal:  Thorax       Date:  1996-11       Impact factor: 9.139

Review 5.  The epidemiology and therapy of airflow limitation in the elderly.

Authors:  L Dow
Journal:  Drugs Aging       Date:  1992 Nov-Dec       Impact factor: 3.923

6.  Bone turnover during short course prednisolone treatment in patients with chronic obstructive airways disease.

Authors:  D Morrison; N J Ali; P A Routledge; S Capewell
Journal:  Thorax       Date:  1992-06       Impact factor: 9.139

Review 7.  A concise review of testosterone and bone health.

Authors:  Nur-Vaizura Mohamad; Ima-Nirwana Soelaiman; Kok-Yong Chin
Journal:  Clin Interv Aging       Date:  2016-09-22       Impact factor: 4.458

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.